Crystallographic Analysis of an 8-mer p53 Peptide Analogue Complexed with MDM2.
Sakurai, K., Schubert, C., Kahne, D.(2006) J Am Chem Soc 128: 11000-11001
- PubMed: 16925398 
- DOI: https://doi.org/10.1021/ja063102j
- Primary Citation of Related Structures:  
2GV2 - PubMed Abstract: 
The most potent inhibitor of the p53-MDM2 interaction reported to date is an 8-mer p53 peptide analogue (Novartis peptide), which contains 6-chlorotryptophane (Cl-Trp) and phosphonomethylphenylalanine (Pmp) as key residues for the enhanced activity. We report here a crystal structure of the co-complex between MDM2 and the Novartis peptide solved at 1.8 A resolution. The structural basis for the role of the two aromatic residues are delineated by comparing the present structure with crystal structures of the MDM2 co-complex bound to other inhibitors including the wt-p53 peptide itself.
Organizational Affiliation: 
Department of Chemistry and Chemical Biology, Harvard University, 12 Oxford Street, Cambridge, Massachusetts 02138, USA.